Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion type Assertion NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_head.
- NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion description "[Several recent advances concerning the influence of human genes in chronic viral hepatitis B and C are discussed in this article: a) the associations between human leukocyte antigen polymorphism and viral hepatic disease susceptibility or resistance; b) protective alleles influencing hepatitis B virus (HBV) and hepatitis C virus (HCV) evolution; c) prejudicial alleles influencing HBV and HCV; d) candidate genes associated with HBV and HCV evolution; d) other genetic factors that may contribute to chronic hepatitis C evolution (genes influencing hepatic stellate cells, TGF-beta 1 and TNF-alpha production, hepatic iron deposits and angiotensin II production, among others).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_provenance.
- NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion evidence source_evidence_literature NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_provenance.
- NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion SIO_000772 15286811 NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_provenance.
- NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion wasDerivedFrom befree-2016 NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_provenance.
- NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_assertion wasGeneratedBy ECO_0000203 NP454071.RAe7z80dCNFxh4-Z7tghlOrlRewz7EBjaQ-tiR5P_2_3M130_provenance.